Old Pharma International
Old Pharma International, founded in 1977, is a leading company in the import and distribution of active pharmaceutical ingredients (APIs). Certified GMP since 2014 and with an AIFA-approved warehouse, it offers a continuously evolving portfolio of products and services to meet the needs of its clients. The company emphasizes quality, sustainability, and innovation, having obtained the EcoVadis 'Committed' badge in 2024. It serves over 100 clients, collaborates with more than 200 suppliers, and manages over 300 APIs. Its mission is to be a reference point in the pharmaceutical sector by providing high-quality APIs, supporting regulatory and scientific needs, and fostering sustainable growth.
Industries
Nr. of Employees
small (1-50)
Old Pharma International
Products
Active Pharmaceutical Ingredients (APIs) portfolio
Catalog of active pharmaceutical ingredients across multiple therapeutic areas supplied from international sources, including compounds produced by chemical synthesis, enzymatic routes or fermentation; covers high‑potency APIs, peptides, corticosteroids and vitamins.
Active Pharmaceutical Ingredients (APIs) portfolio
Catalog of active pharmaceutical ingredients across multiple therapeutic areas supplied from international sources, including compounds produced by chemical synthesis, enzymatic routes or fermentation; covers high‑potency APIs, peptides, corticosteroids and vitamins.
Services
Identification and procurement of active pharmaceutical ingredients from a global supplier network to supply regulated markets.
Regulatory consulting and technical‑scientific assistance covering authorization strategies, certification support, technical evaluations and regulatory compliance management related to APIs and distribution.
Market outreach, partnership development and representation at industry events to support market access and commercial expansion of API portfolios.
Risk‑based services including supply diversification, market monitoring, contingency logistics and continuity planning to mitigate drug shortages and ensure supply reliability.
Identification and procurement of active pharmaceutical ingredients from a global supplier network to supply regulated markets.
Regulatory consulting and technical‑scientific assistance covering authorization strategies, certification support, technical evaluations and regulatory compliance management related to APIs and distribution.
Market outreach, partnership development and representation at industry events to support market access and commercial expansion of API portfolios.
Risk‑based services including supply diversification, market monitoring, contingency logistics and continuity planning to mitigate drug shortages and ensure supply reliability.
Expertise Areas
- API sourcing and distribution for regulated markets
- GMP‑compliant warehousing and GDP distribution
- Cold‑chain logistics for temperature‑sensitive APIs
- Regulatory compliance, import authorizations and inspection readiness
Key Technologies
- Chemical synthesis of APIs
- Enzymatic synthesis processes
- Fermentation‑based API production
- Cold‑chain temperature monitoring and control
News & Updates
Old Pharma and Prodotti Gianni collaborated for the first time at CPHI Milano 2024, a major international event.
The event concluded successfully, opening new opportunities for the companies.
An article about the antibiotic Amikacin, effective against serious Gram-negative bacterial infections.
Old Pharma achieved the 'Committed' badge from EcoVadis, a milestone in its ESG journey.
An article discussing the impact of AI and Generative AI in the pharmaceutical industry.
Coverage of the successful participation of Old Pharma and Prodotti Gianni at CPHI Milan 2024.
Old Pharma and Prodotti Gianni collaborated for the first time at CPHI Milano 2024, a major international event.
The event concluded successfully, opening new opportunities for the companies.
An article about the antibiotic Amikacin, effective against serious Gram-negative bacterial infections.
Old Pharma achieved the 'Committed' badge from EcoVadis, a milestone in its ESG journey.
An article discussing the impact of AI and Generative AI in the pharmaceutical industry.
Coverage of the successful participation of Old Pharma and Prodotti Gianni at CPHI Milan 2024.